Page 92 - 《中国药房》2023年16期

www.jmcm2018.com/CN/Y2021/V7/I3/17. DOI：10.12151/ [18] DRAMPALOS E，SKARPAS G，BARBOUNAKIS N，et
JMCM.2021.03-04. al. Atypical femoral fractures bilaterally in a patient re‐
[ 5 ] 牛晓辉. 骨巨细胞瘤的地舒单抗药物治疗[J]. 中国骨与 ceiving denosumab[J]. Acta Orthop，2014，85（1）：3-5.
关节杂志，2021，10（2）：81-84. [19] SUGIHARA T，KOIZUMI M，HAYAKAWA K，et al. Im‐
[ 6 ] SHANE E，BURR D，ABRAHAMSEN B，et al. Atypical pending atypical femoral fracture in a patient of breast
subtrochanteric and diaphyseal femoral fractures：second cancer with bone metastases receiving long-term deno‐
report of a task force of the American Society for Bone sumab[J]. Clin Nucl Med，2018，43（5）：365-366.
and Mineral Research[J]. J Bone Miner Res，2014，29（1）： [20] SCHILCHER J，ASPENBERG P. Atypical fracture of the
1-23. femur in a patient using denosumab：a case report[J]. Acta
[ 7 ] STARR J，TAY Y K D，SHANE E. Current understanding Orthop，2014，85（1）：6-7.
of epidemiology，pathophysiology，and management of [21] PAPARODIS R，BUEHRING B，PELLEY E M，et al. A
atypical femur fractures[J]. Curr Osteoporos Rep，2018，16 case of an unusual subtrochanteric fracture in a patient re‐
（4）：519-529. ceiving denosumab[J]. Endocr Pract，2013，19（3）：e64-
[ 8 ] YANG S P，KIM T W，BOLAND P J，et al. Retrospective e68.
review of atypical femoral fracture in metastatic bone di- [22] VILLIERS J，CLARK D W，JESWANI T，et al. An atrau‐
sease patients receiving denosumab therapy[J]. Oncologist， matic femoral fracture in a patient with rheumatoid arthri‐
2017，22（4）：438-444. tis and osteoporosis treated with denosumab[J]. Case Rep
[ 9 ] WARREN A M，EBELING P R，GRILL V，et al. Bilateral Rheumatol，2013，2013：249872.
atypical femoral fractures during denosumab therapy in a [23] PIPONOV H I，GOLDSTEIN J M，EISENBERG G M.
patient with adult-onset hypophosphatasia[J]. Endocrinol Multiple ipsilateral femoral stress fractures in a patient
Diabetes Metab Case Rep，2021，2021：21-0096. taking denosumab for osteoporosis：a case report[J].
[10] THOMPSON R N，ARMSTRONG C L，HEYBURN G. Osteoporos Int，2020，31（11）：2263-2267.
Bilateral atypical femoral fractures in a patient prescribed [24] NASCA V，FREZZA A M，MOROSI C，et al. Rechallenge
denosumab：a case report[J]. Bone，2014，61：44-47. of denosumab in advanced giant cell tumor of the bone
[11] NEZU K，ENDO Y，KATAYAMA H，et al. Case of atypi‐ after atypical femur fracture：a case report and review of
cal femoral fractures that mimicked the typical imaging literature[J]. Front Oncol，2022，12：953149.
findings of prostate cancer-induced bone metastasis[J]. [25] BINKLEY N，GOEL H，SHIVES E，et al. A probable
IJU Case Rep，2019，2（6）：303-306. atypical ulnar fracture in a man receiving denosumab[J].
[12] KUMAR S，CHANG R，REYES M，et al. Atypical femo‐ Bone，2021，143：115726.
ral fracture in a bisphosphonate-naive patient on deno‐ [26] MURAI A，TADA，NAKAJIMA T，et al. Case report：pro‐
sumab for osteoporosis[J]. Arch Osteoporos，2022，17 phylactic plate fixation for incomplete atypical ulnar frac‐
（1）：131. tures resulting from the use of denosumab for bone meta-
[13] SELGA J，NUÑEZ J H，MINGUELL J，et al. Simulta- stases[J]. Front Endocrinol（Lausanne），2022，12：798653.
neous bilateral atypical femoral fracture in a patient re- [27] OKUBO N，YOSHIDA T，OHARA M，et al. Atypical
ceiving denosumab：case report and literature review[J]. ulnar fracture in an older woman with osteoporosis with
Osteoporos Int，2016，27（2）：827-832. a five-year history of denosumab treatment：a case report
[14] DUPAIX J P，OPANOVA M I，LEE L S K，et al. Deno- [J]. J Hand Surg Asian Pac Vol，2022，27（5）：928-932.
sumab-associated peri-implant atypical femur fracture：a [28] BLACK D M，GEIGER E J，EASTELL R，et al. Atypical
case report[J]. Hawaii J Health Soc Welf，2019，78（11 femur fracture risk versus fragility fracture prevention
Suppl 2）：47-51. with bisphosphonates[J]. N Engl J Med，2020，383（8）：
[15] GOH J K M，KOH J S B，NG A C M，et al. Bilateral atypi‐ 743-753.
cal femur fractures after denosumab in a bisphosphonate [29] YAMAMOTO N，YAMAUCHI M，NODA T，et al. Atypi‐
naive patient：a case report[J]. Calcif Tissue Int，2022，111 cal ulnar fracture with atypical femoral fracture：a case re‐
（1）：96-101. port and literature review[J]. J Orthop Sci，2022，27（6）：
[16] AUSTIN D C，TORCHIA M T，KLARE C M，et al. Atypi‐ 1354-1358.
cal femoral fractures mimicking metastatic lesions in 2 pa‐ [30] BANFFY M B，VRAHAS M S，READY J E，et al. Non-
tients taking denosumab[J]. Acta Orthop，2017，88（3）： operative versus prophylactic treatment of bisphosphonate-
351-353. associated femoral stress fractures[J]. Clin Orthop Relat
[17] KHOW K S F，YONG T Y. Atypical femoral fracture in a Res，2011，469（7）：2028-2034.
patient treated with denosumab[J]. J Bone Miner Metab， （收稿日期：2023-01-12 修回日期：2023-07-06）
2015，33（3）：355-358. （编辑：陈 宏）

· 2002 · China Pharmacy 2023 Vol. 34 No. 16 中国药房 2023年第34卷第16期